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ABSTRACT
Objectives: Although pain is a significant symptom in
chronic fatigue syndrome (CFS), pain is poorly
understood in adolescents with CFS. The aim of this
study was to explore pain distribution and prevalence,
pain intensity and its functional interference in
everyday life, as well as pressure pain thresholds (PPT)
in adolescents with CFS and compare this with a
control group of healthy adolescents (HC).
Methods: This is a case–control, cross-sectional
study on pain including 120 adolescents with CFS and
39 HCs, aged 12–18 years. We measured pain
frequency, pain severity and pain interference using
self-reporting questionnaires. PPT was measured using
pressure algometry. Data were collected from March
2010 until October 2012 as part of the Norwegian
Study of Chronic Fatigue Syndrome in Adolescents:
Pathophysiology and Intervention Trial.
Results: Adolescents with CFS had significantly lower
PPTs compared with HCs (p<0.001). The Pain Severity
Score and the Pain Interference Score were significantly
higher in adolescents with CFS compared with HCs
(p<0.001). Almost all adolescents with CFS experienced
headache, abdominal pain and/or pain in muscles and
joints. Moreover, in all sites, the pain intensity levels
were significantly higher than in HCs (p<0.001).
Conclusions: We found a higher prevalence of severe
pain among adolescents with CFS and lowered pain
thresholds compared with HCs. The mechanisms,
however, are still obscure. Large longitudinal population
surveys are warranted measuring pain thresholds prior
to the onset of CFS.
Trial registration number: Clinical Trials,
NCT01040429; The Norwegian Study of Chronic Fatigue
Syndrome in Adolescents: Pathophysiology and
Intervention Trial (NorCAPITAL) http://www.
clinicaltrials.gov.
INTRODUCTION
Chronic fatigue syndrome (CFS) is a well-
known condition among adolescents, with an
estimated prevalence from 0.1% to 1.0%.1 2
However, despite growing research, it is still a
poorly understood disorder and there is no
general agreement for a reference standard
for diagnosis. According to US Centers for
Disease Control (CDC-1994), a CFS diagnosis
requires three criteria: (1) severe chronic
fatigue for 6 or more consecutive months,
(2) fatigue that signiﬁcantly interferes with
daily activities and (3) at least four of eight
accompanying symptoms. Five of these eight
symptoms are regarding pain.3 For some
patients, the ongoing pain is even more dis-
abling than fatigue4 and is associated with
poor physical function.5 Although the
CDC-1994 criteria for CFS are frequently
used, the requirement regarding the number
of accompanying symptoms has been ques-
tioned.6–8 A recent review found no evidence
that any case deﬁnitions (diagnostic criteria)
for CFS identiﬁed patients with speciﬁc
disease aetiology.9 For children and adoles-
cents, there are speciﬁc recommendations
with a broad case deﬁnition, requiring
3 months of unexplained disabling, chronic/
relapsing fatigue of new onset.10 11 Although
some deﬁnitions emphasise pain as an
important component,3 12 this symptom is
Strengths and limitationsof this study
▪ This is one of the first large studies to test and
to discuss pressure-provoked pain in adolescents
with chronic fatigue syndrome (CFS) and healthy
adolescents.
▪ The relatively large sample of patients together
with few missing data strengthens the study and
makes it possible to generalise the findings. On
the other hand, the study only included patients
who were able to attend our research clinic; and
the results cannot be extrapolated to the most
seriously affected CFS adolescents.
▪ The study could have benefitted from a larger
sample of healthy controls.
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often ignored by clinicians and researchers13 and little
progress has been made in understanding the pain com-
ponent in patients with CFS.14 Patients with CFS report
increased sensitivity to stimuli such as light and sound,15
and some researchers have hypothesised that the pain is
caused by increased sensitivity of the nervous system,16–
18 deﬁned as an “increased responsiveness to normal or
sub-threshold input.”19 Based on the theory of the cog-
nitive activation theory of stress, the sustained arousal
theory was suggested as a mechanism for the develop-
ment of CFS, resulting in several bodily symptoms,
including pain.20 Hypersensitivity, measured by means of
pressure has been investigated in the adult CFS popula-
tion, but only with a small number of patients.18 To the
best of our knowledge, hypersensitivity measured by
pressure has been insufﬁciently studied in adolescents
with CFS using a control group of healthy adolescents.
One exception is a study by van de Putte et al,21 ﬁnding
that there is considerably lowered pressure pain thresh-
old (PPT) in adolescents with CFS compared with a
group of healthy controls (HCs), but the authors did
not discuss the lowered PPT in adolescents with CFS
other than stating the difference. So far, the pain
research on adolescents with CFS has focused on the
cluster of symptoms characterising CFS.1 8 22 23 One way
to detect if there is an increased sensitivity is to compare
pressure PPT in symptomatic and asymptomatic areas in
patients with CFS to HCs.13 The deﬁnition of pain as
described by The International Association for the Study
of Pain (IASP) emphasises that pain is a complex
concept.24 Thus, there is a need for a broad approach to
understanding pain in patients with CFS.
The aim of this study was to evaluate pain in adoles-
cents with CFS compared with healthy adolescents and,
more speciﬁcally, to explore: (1) the prevalence and loca-
tion of pain symptoms, (2) pain severity and its functional
interference on everyday life and (3) baseline PPTs.
MATERIALS AND METHODS
Design
This is a case–control, cross-sectional study, which com-
pares pain (frequency, severity and interference) and
PPTs in adolescents with CFS to a comparable group of
healthy adolescents. The study is part of the
NorCAPITAL project (The Norwegian Study of Chronic
Fatigue Syndrome in Adolescents: Pathophysiology and
Intervention Trial; Clinical Trials ID: NCT01040429),
which explores possible mechanisms of CFS, the effect
of low-dose clonidine treatment and patients’ experi-
ences in adolescents with CFS.15
Participants
Patients with CFS
One hundred and twenty adolescents with CFS and 39
adolescents without any known health problem were
recruited between March 2010 and March 2012. All paedi-
atric departments in Norwegian hospitals (n=20), as well
as primary care paediatricians and general practitioners,
were invited to refer adolescents with CFS (table 1). The
Table 1 Criteria for inclusion and exclusion
Patients with CFS Healthy control participants
Inclusion
criteria
Persisting or constantly relapsing fatigue lasting 3 months or more
Functional disability resulting from fatigue to a degree that prevents
normal school attendance
Age ≥12 and <18 years
Age ≥12 and <18 years
Exclusion
criteria
Another current process or chronic disease or demanding life event
that might explain the fatigue
Permanent use of drugs (including hormones) possibly interfering with
measurements
Permanently bed-ridden
Positive pregnancy test
Pheochromocytoma
Evidence of reduced cerebral and/or peripheral circulation due to
vessel disease
Polyneuropathy
Renal insufficiency
Known hypersensitivity towards clonidine or inert substances (lactose,
saccharose) in capsula
Abnormal ECG (apart from ectopic beats)
Supine heart rate <50 bpm
Supine systolic blood pressure <85 mm Hg
Upright systolic blood pressure fall >30 mm Hg
Another chronic disease
Permanent use of drugs (including
hormones)
The criteria are designed for the randomised control trial in the NorCAPITAL project (The Norwegian Study of Chronic Fatigue Syndrome in
Adolescents: Pathophysiology and Intervention Trial; Clinical Trials ID: NCT01040429), which explores possible mechanisms of CFS, the
effect of low-dose clonidine treatment and patients’ experiences in adolescents with CFS (9).
CFS, chronic fatigue syndrome.
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referring units were required to conﬁrm that the patients
did not have any medical or psychiatric disorder that
might explain the fatigue. In agreement with clinical
guidelines,10 11 a ‘broad’ case deﬁnition with 3 months of
unexplained, disabling fatigue of new onset was required.
We did not require any other accompanying symptom cri-
teria to be present. However, we required that the patient
(A) was unable to follow normal school routines due to
fatigue; (B) was not permanently bedridden; (C) did not
use pharmaceuticals (including hormone contraceptives)
regularly. Those who fulﬁlled the prespeciﬁed criteria for
inclusion (table 1) were included in the NorCAPITAL
study. Most participants (75%) satisﬁed the Fukuda criteria
from the International Chronic Fatigue Syndrome Study
Group.3 There are disagreements on the numbers of
accompanying symptoms that have to be present for the
diagnosis of CFS. At present, there is no evidence for an
obvious cut-off for the number of symptoms.11
A control group of healthy adolescents
To recruit a control group of healthy adolescents, infor-
mation of the study was sent to local schools. Those who
replied were given extended information. No regular
use of pharmaceuticals was allowed. A group of 39 ado-
lescents, reporting themselves as healthy and normally
active and matched on gender and age, was enrolled.15
Measures
Brief Pain Inventory
To assess pain, the Brief Pain Inventory (BPI) was
used.25 BPI assesses the intensities of pain and to what
extent pain interferes with different aspects of life.26
The Norwegian version of BPI has been validated in
cancer pain patients.27 The questionnaire has also been
validated in several chronic non-malign and musculo-
skeletal disorders28 29 and in youths with neuromuscular
diseases.30 The numeric rating scale has been shown
appropriate for use with children from 5 years of age.31
Modiﬁed versions of the BPI interference score has
been used in previous studies with participants aged
between 8 and 20.32 33
In order to reduce the total burden of questions, we
removed the question about pain interference with
sleep, and to make it more age-relevant, we asked how
pain affected school and homework instead of asking
how pain affected work. ‘Total Pain Severity Score’ was
expressed as the mean of the four pain intensity items
while ‘Total Pain Interference Score’ was obtained by
calculating the mean of the seven interference items.28
By removing the question about sleep we ended up with
six interference scores that were averaged. Internal con-
sistency of the modiﬁed questionnaire was assessed with
Cronbach’s α computed separately for cases and con-
trols. The values were 0.89 and 0.87 for cases and con-
trols, respectively.
Each item from BPI was read aloud by one of the
researchers and answered by the participant. In the
body diagram of BPI, patients were asked to indicate the
location of their pain by shading the areas correspond-
ing to painful areas of their own body.
CFS questionnaire
A comprehensive CFS questionnaire was constructed
and used in the NorCAPITAL study,15 and in the present
study, we focused on four questions from this inventory
related to pain: headache, pain in muscles, pain in joint
(s) and pain in the abdomen. Frequency of pain was
measured on a ﬁve-point Likert scale. Single item ques-
tions about pain have shown to be reliable in measuring
pain in children and adolescents.34 In contrast to the
BPI, which was ﬁlled in at the hospital, the CFS inven-
tory was ﬁlled in by the participants at home and
returned in prestamped envelopes within a few weeks.
All measures were performed at baseline, 8 weeks after
inclusion and 30 weeks after inclusion. Only the baseline
data are presented here.
Pressure pain threshold
PPT is a reliable variable to test for hyperalgaesia in
superﬁcial structures such as skin, nails and underlying
muscles.35 The pain threshold is deﬁned by IASP (1986)
as “the minimum intensity of a stimulus that is perceived
as painful.”19 Pressure provoked pain thresholds were
mapped using a commercially available force transducer
with a rubber tip of 0.5 cm2 (Algometer, JTECH,
medical, Salt Lake City, Utah, USA). Values are pre-
sented in Newton (N). The intensity was increased until
the PPT was reached. For each person we assessed all
sites in the same order. We intended to measure PPTs at
places where people commonly have pain (trapezius
and supraspinatus), as well as at places that rarely hurt
(ﬁngernails) and selected three predeﬁned sites: (1) the
ﬁngernail of the third ﬁnger, (2) skin superﬁcial to the
trapezius (ascending part) and (3) supraspinatus
muscles bilaterally. Reduced thresholds on symptomatic
as well as asymptomatic/remote places may indicate a
general sensitisation.18 To ensure reliability, the pressure
stimuli were applied twice to each spot and then aver-
aged, a procedure that is commonly used in other
studies to ensure reliability.36 The participants were
instructed to indicate pain threshold by saying ‘stop’. In
between the two measurements, they ﬁlled in the BPI
assessment form, which took about 10 min to complete.
The researcher was not blinded regarding patients with
CFS and HCs.
Ethical considerations
Participation in the project required informed consent
by the adolescent and by their parents/next-of-kin, after
written and oral information about the study.
Statistical analyses
Continuous variables are presented with medians and
ranges while categorical variables are described as
counts and percentages. Pain intensity and pain interfer-
ence were measured on ordinal scales, and group
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differences were therefore analysed by a non-parametric
test (Mann-Whitney-Wilcoxon test). For frequency differ-
ences between the groups, the χ2 test was applied. An
average of two pain pressure threshold measurements
were calculated for three body parts on each body side.
As the values were normally distributed in both groups,
they were compared using two independent samples t
tests.
To assess internal consistency of the instruments,
Cronbach’s α was computed separately for cases and
controls. α>0.7 was considered acceptable.37 All tests
were two sided and, due to multiple testing, only p
values <0.01 were considered statistically signiﬁcant. All
analyses were performed using SPSS, IBM Statistics V.20.
RESULTS
In the whole sample (including the CFS and the control
group), about 25% were males and 75% females. Mean
age was 15.4 years (SD 1.6) for patients and 15.2 (SD 1.6)
for HCs. There were almost no missing data in any of the
data sets (details are given in tables 2 and 3). There were
no statistically signiﬁcant differences between cases and
controls concerning possible confounders (age, body
mass index and gender distribution), and there was no
difference between patients and controls regarding socio-
economic status (table 4).
Pain prevalence and distribution
The frequency data from the CFS Symptom Inventory
showed that adolescents with CFS were, on a weekly
basis, seriously inﬂuenced by pain (table 2). Summing
up the categories 3, 4 and 5 in table 2 (1–2 times/week,
3–5 times/week and approximately every day), almost all
adolescents with CFS versus one-third of the HCs
reported pain during the previous week, and the group
difference was highly signiﬁcant. Headache was most
common (67% reported weekly attacks), followed by
muscle pain (62%), pain in joints (53%) and abdominal
pain (49%). Headache was also the most reported pain
in HCs (13%), followed by pain in muscles (11%) and
abdominal pain (6%). No HCs reported pain in joints
as a problem on a weekly basis. Studying the body map,
almost 30% of the patients with CFS marked more than
four sites as painful while none of the HCs did (table 5).
Pain severity and functional interference
Patients with CFS demonstrated higher Pain Severity
Scores (p<0.001) and Pain Interference Scores
Table 2 Frequency of pain episodes in different locations among patients with CFS and healthy controls
Frequency
Patients with CFS, n=120 (%) Healthy controls, n=39 (%)
Head Abdomen Joints Muscles Head Abdomen Joints Muscles
0–1 times/month 9 (8) 30 (25) 36 (30) 21 (18) 18 (46) 20 (51) 35 (90) 26 (67)
2–3 times/month 28 (23) 30 (25) 19 (16) 20 (17) 14 (36) 15 (39) 2 (5) 7 (18)
1–2 times/week 28 (23) 21 (18) 24 (20) 24 (20) 4 (10) 1 (3) 0 2 (5)
3–5 times/week 20 (17) 21 (18) 15 (13) 17 (14) 0 1 (3) 0 1 (3)
∼Every day 32 (27) 15 (13) 23 (20) 34 (28) 1 (3) 0 0 1 (3)
Missing (%) 2.5 2.5 2.5 3.3 5.1 5.1 5.1 5.1
Group comparisons for different pain sites (head, abdomen, joints and muscles); p<0.001 for all four sites.
CFS, chronic fatigue syndrome.
Table 3 Pain Intensity, Severity and Interference scores among patients with CFS and healthy controls
Patients with CFS Healthy controls
p Value*n Median (range) n Median (range)
Pain worst 117 6 (0–10) 39 3 (0–10)
Pain least 118 1 (0–7) 39 0 (0–7)
Pain average 118 5 (0–9) 39 3 (0–6)
Pain now 118 2 (0–8) 39 0 (0–7)
Total Pain Severity Score 117 14.5 (0–31) 39 6 (0–23) <0.001
Interference in
General activity 118 4 (0–10) 39 1 (0–8)
Mood 118 3 (0–9) 39 1 (0–8)
Walking 118 2 (0–10) 39 0 (0–7)
School 118 4 (0–10) 39 0 (0–8)
Relation to others 118 2 (0–9) 39 0 (0–8)
Enjoyment of life 118 2 (0–9) 39 0 (0–10)
Total Pain Interference Score 118 17 (0–49) 39 4 (0–36) <0.001
*Statistical group comparisons; Mann-Whitney-Wilcoxon test.
CFS, chronic fatigue syndrome.
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(p<0.001) than HCs. Among the patients with CFS, pain
interfered most with attendance at school and general
activity (table 3). Ability to enjoy life, however, was one
of the life domains that was least affected by pain,
among patients with CFS and also among HCs; but it is
important to notice that 8.4% of the adolescents with
CFS scored above seven on this item. Three HCs scored
high (≥8) on pain severity while four on pain interfer-
ence, reﬂecting the large variation in the normal
population.
Pressure pain thresholds
At all measure points, PPTs were signiﬁcantly lower (all
p<0.001) among patients with CFS than HCs. For the
trapezius muscle, the mean values were 15.4, 95% CI
(14.1 to 16.8) and 24.5, 95% CI (21.0 to 28.0) for cases
and controls, respectively. On ﬁngernails 18.5, 95% CI
(16.9 to 20.0) for cases and 30.8, 95% CI (26.5 to 35.4)
for controls. Concerning supraspinatus muscle the mean
values were 17.1, 95% CI (15.6 to 18.6) for cases and
27.7, 95% CI (23.3 to 31.6) for controls. The values
show that PPT was as much as 50% lower in patients
with CFS than in HCs, at locations that usually are
painful (muscles) as well as in areas that usually are not
reported painful (ﬁnger nails). There were no missing
data for HCs and for patients with CFS data were
missing for one individual.
DISCUSSION
This study shows that adolescents with CFS have signiﬁ-
cantly lower pain thresholds than a comparable control
group of healthy adolescents. The study also demon-
strates that adolescents with CFS are severely troubled by
pain and that pain has great functional consequences. A
more unexpected ﬁnding is the lower pain interference
on joy of life for the patients.
Hypersensitivity
The signiﬁcantly lower PPTs among adolescents with
CFS compared with HCs in symptomatic and asymptom-
atic places could indicate a more general sensitisation of
the nervous system.38 Lowered PPT in asymptomatic
areas, indicating general sensitisation, has also been
found in patients with Ehlers-Danlos syndrome.36
General hypersensitivity has been suggested as a reason
for pain among patients with CFS, as it has for chronic
widespread pain16 and ﬁbromyalgia.39 Our own research
group found signiﬁcantly higher sensitivity scores among
adolescents with CFS and hypothesises that the hyper-
sensitivity could be an effect of sustained arousal.15
Other researchers have highlighted altered pain inhib-
ition as a potential factor in patients with generalised
pain.40 Patients with CFS have also reported being more
sensitive to other sensory stimulations such as light and
sound.15 41 Thus, it might be the case that adolescents
with CFS are more sensitive to several types of sensory
stimuli. On the other hand, it should be borne in mind
that lowered PPT only reﬂects increased sensitivity to
mechanical stimuli, and does not predict the response
to, for instance, thermal stimuli.
Researchers have suggested that patients with CFS are
genetically more prone to develop the disease,20 in line
with epidemiological data on chronic pain.42 The factors
and processes for pain among patients with CFS remain
unclear, but in other populations, pain beliefs, emotions,
understanding of pain and psychosocial factors have
been found to inﬂuence the perception of pain.43 In
patients with ﬁbromyalgia, Turk43 showed that fear of
movement maintains the pain experience and increases
the disability. The model on pain-related fear and avoid-
ance suggests this as essential for perpetuation of pain,44
and among adults with CFS, Nijs et al45 demonstrate a
clear association between pain catastrophising, pain
severity and activity limitation/participation. There is no
obvious reason to believe that this is not the case for
adolescents with CFS. Negative thoughts may also
develop when patients do not understand the aetiology
Table 4 Demographic data and adherence to specific
CFS criteria (Fukuda, 1994)
Patients
with CFS
n=120
Controls
n=39
Male, n (%) 34 (28) 11 (28.2)
Female, n (%) 86 (72) 28 (71.8)
Age (years), mean (SD) 15.4 (1.6) 15.2 (1.6)
Disease duration (months),
Mean (range)
21.4 (4–104) NA
Fukuda criteria, n (%) 88 (75) NA
Lives with both parents, n (%) 85 (73) 26 (70)
Parents’ highest education, n (%)
Primary school 5 (4.3) 0 (0)
Secondary school 30 (26) 8 (23)
Lower university 34 (29) 9 (23)
Higher university 48 (41) 19 (54)
n, number of individuals; CFS, chronic fatigue syndrome.
Table 5 Number of body sites mapped as painful among
patients with CFS and healthy controls
Patients with CFS
n=117
Healthy controls
n=39
0 locations, n (%) 8 (7) 7 (18)
1 location, n (%) 13 (11) 13 (33)
2 locations, n (%) 19 (16) 10 (10)
3 locations, n (%) 30 (26) 5 (5)
4 locations, n (%) 13 (11) 4 (10)
5 locations, n (%) 17 (15) 0 (0)
6 locations, n (%) 6 (5) 0 (0)
7 locations, n (%) 11 (9) 0 (0)
The located areas shaded are head, neck/shoulder, chest, back,
abdomen, upper limb, lower limb. Only the counted number of
locations are presented in the table.
n, number of individuals; CFS, chronic fatigue syndrome.
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of pain.36 A qualitative study suggests that multiple per-
spectives, including individual differences, developmen-
tal and relational focus, should be taken into account
when treating and studying young persons with CFS.46
Cognitive behaviour therapy for CFS has shown to be
effective in improving fatigue and pain in adults and
adolescents.4 A multidimensional perspective of CFS,
opposing the dichotomy between bodily and mental pro-
cesses and acknowledging the impact of cognitive pro-
cesses on physiological responses, is supported by
previous studies47 48 and is in line with the sustained
arousal theory.20
More knowledge about pain and the relation to
increased sensitivity before and throughout the process
of the illness might provide a better understanding of
CFS. Except for one study (published as editorial letter
2013) showing improvement in pain and pain threshold
after successful cognitive behaviour therapy,49 we are not
aware of other published studies focusing on this aspect
in adolescents with CFS.
Frequency of pain
In the present study, almost three-quarters of the adoles-
cents with CFS suffered from weekly pain, and pain on a
daily basis was a problem for half of the patients. HCs
also reported pain on a weekly basis, but the rates were
much lower. Pain is indeed a common problem among
teenagers in general50–53; in a large Norwegian health
survey, 10% of healthy adolescents reported pain on a
daily basis and 19% were troubled by musculoskeletal or
abdominal pain.52 In our study, nearly half of the adoles-
cents with CFS reported abdominal pain every week.
Such a high proportion of recurrent abdominal pain
has also been reported in a study on CFS adolescents
from the UK.54 These authors demonstrated in another
study the same somatic symptoms among HCs and ado-
lescents with CFS, although with a lower degree of sever-
ity in HCs55; headache and sore muscles were among
the top 10 bodily complaints. Our study conﬁrms these
ﬁndings. Adolescents with CFS report pain in the same
places as the HCs do, although the pain frequency is
higher. In both groups, headache is the most common
pain followed by abdominal pain.
The largest group difference in the present study was
joint pain. Of the HCs, only 10% reported joint pain
more frequently than once a month, versus 70% of the
adolescents with CFS.
Pain severity and interference in daily life
From HCs we know that physical activity has an import-
ant pain protective effect,52 and Crawley and Stern5 have
shown that impaired physical function is associated with
higher levels of fatigue, pain and low mood.
Complicating this, pain thresholds in patients with CFS
have been found to decrease after physical exercises,56
which may lead to a fear avoidance behaviour. This phe-
nomenon illustrates how several contributing factors
may inﬂuence the pain condition.
Although average Pain Severity Scores were relatively
moderate in the CFS group (table 3), healthcare provi-
ders should bear in mind that the total sum of pain and
fatigue over time might represent a heavy burden with
serious long-term consequences.48 Large studies on pain
in children and adolescents have demonstrated substan-
tial reductions in quality of life (QOL).50 57 58 In our
study, the adolescents reported that pain interfered with
school, general activity and mood; however, we cannot
conclude from this study that pain has a causal effect,
because it could be the other way around. Particularly
interference with school attendance has been shown to
strongly affect QOL in adolescents with CFS.55 59 Some
of our patients felt it was difﬁcult to assess the interfer-
ence of pain, and to separate what was caused by fatigue
and what was caused by pain, and the second part of
BPI (mapping the interference of pain) has for that
reason been criticised.27 Although the participants were
told to concentrate on pain and not the fatigue, we
realise that QOL is most likely to be affected by both.
It is important to bear in mind that the economical
differences between social classes are not as pronounced
in Norwegian society as in other Western societies, and
all individuals in Norway have equal access to medical
care; and using level of education as a surrogate for
social class, we still found no difference between the two
groups.
Strengths and limitations
This is one of the ﬁrst studies to include a broader focus
on pain in adolescents with CFS, and to test pressure-
provoked pain in adolescents with CFS and in healthy
adolescents. The relatively large sample of patients
together with few missing data strengthens the study,
making it possible to generalise the results. The wide
inclusion criteria suggest generalisability to the popula-
tion of adolescents with CFS referred to paediatric care.
Only two patients reported a short disease duration
between 3 and 6 months,15 and the results should be
generalisable to populations with a more persistent CFS
condition (more than 6 months). The NorCAPITAL
study did have one clear selection bias, as the study only
included patients who were able to attend our research
clinic; and the results cannot be extrapolated to the
most seriously affected CFS adolescents. One question
from the original BPI questionnaire was removed and
this might have affected the psychometric property.
However, Cronbach’s α computed for BPI interference
scores demonstrated strong internal consistency for both
cases and controls. The results could have been inﬂu-
enced by confounding factors such as anxiety and
depression. In a previous paper from our research
group, on the same group of patients, however, we did
not ﬁnd depression to be a confounding factor.15 The
control group of adolescents is smaller than the CFS
group, and the study might have beneﬁtted from a
larger sample of controls. Power calculation from a pre-
vious study,47 however, gives reasons to assume that our
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samples were sufﬁcient to discover signiﬁcantly and clin-
ically interesting group differences.15
CONCLUSION
We found a higher prevalence of severe pain among
adolescents with CFS and lowered pain thresholds com-
pared with HCs. The total sum of bodily symptoms
represented a heavy burden with great functional conse-
quences. The large sample of patients together with few
missing data strengthens the study, making it possible to
generalise the results.
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